#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=3. Discussion
1-1	0-2	3.	_	_	_	_
1-2	3-13	Discussion	abstract	new	_	_

#Text=So far , S. griseorubens species has mainly been found in soils and was previously demonstrated as a strong antagonistic species conveying broad antifungal activities .
2-1	14-16	So	_	_	_	_
2-2	17-20	far	_	_	_	_
2-3	21-22	,	_	_	_	_
2-4	23-25	S.	person|animal[4]	new|new[4]	coref|coref|coref|coref	3-15|7-33[51_4]|3-15|7-33[51_4]
2-5	26-38	griseorubens	animal|animal[4]	new|new[4]	coref	3-15[12_0]
2-6	39-46	species	animal[4]	new[4]	_	_
2-7	47-50	has	_	_	_	_
2-8	51-57	mainly	_	_	_	_
2-9	58-62	been	_	_	_	_
2-10	63-68	found	_	_	_	_
2-11	69-71	in	_	_	_	_
2-12	72-77	soils	substance	new	_	_
2-13	78-81	and	_	_	_	_
2-14	82-85	was	_	_	_	_
2-15	86-96	previously	_	_	_	_
2-16	97-109	demonstrated	_	_	_	_
2-17	110-112	as	_	_	_	_
2-18	113-114	a	_	_	_	_
2-19	115-121	strong	_	_	_	_
2-20	122-134	antagonistic	_	_	_	_
2-21	135-142	species	_	_	_	_
2-22	143-152	conveying	_	_	_	_
2-23	153-158	broad	abstract[6]	new[6]	_	_
2-24	159-169	antifungal	abstract[6]	new[6]	_	_
2-25	170-180	activities	abstract[6]	new[6]	_	_
2-26	181-182	.	_	_	_	_

#Text=The present research revealed for the first time the activity of the endophytic actinomycete S. griseorubens MPT42 isolated from the stem of L. cubeba .
3-1	183-186	The	abstract[7]	new[7]	_	_
3-2	187-194	present	abstract[7]	new[7]	_	_
3-3	195-203	research	abstract[7]	new[7]	_	_
3-4	204-212	revealed	_	_	_	_
3-5	213-216	for	_	_	_	_
3-6	217-220	the	time[8]	new[8]	_	_
3-7	221-226	first	time[8]	new[8]	_	_
3-8	227-231	time	time[8]	new[8]	_	_
3-9	232-235	the	abstract[9]	new[9]	coref	4-5[18_9]
3-10	236-244	activity	abstract[9]	new[9]	_	_
3-11	245-247	of	abstract[9]	new[9]	_	_
3-12	248-251	the	abstract[9]|person[10]	new[9]|new[10]	_	_
3-13	252-262	endophytic	abstract[9]|person[10]	new[9]|new[10]	_	_
3-14	263-275	actinomycete	abstract[9]|person[10]	new[9]|new[10]	_	_
3-15	276-278	S.	person|animal[12]|abstract[13]	giv|giv[12]|new[13]	ana|coref|coref|ana|coref|coref|ana|coref|coref	4-1[0_13]|6-27|6-26[35_12]|4-1[0_13]|6-27|6-26[35_12]|4-1[0_13]|6-27|6-26[35_12]
3-16	279-291	griseorubens	animal[12]|abstract[13]	giv[12]|new[13]	_	_
3-17	292-297	MPT42	abstract[13]	new[13]	_	_
3-18	298-306	isolated	_	_	_	_
3-19	307-311	from	_	_	_	_
3-20	312-315	the	place[14]	new[14]	ana	5-1[0_14]
3-21	316-320	stem	place[14]	new[14]	_	_
3-22	321-323	of	place[14]	new[14]	_	_
3-23	324-326	L.	place[14]	new[14]	_	_
3-24	327-333	cubeba	place[14]	new[14]	_	_
3-25	334-335	.	_	_	_	_

#Text=Its CEAE extract exhibited a broad-spectrum antimicrobial activity toward various microbial types including drug-sensitive and multidrug-resistant pathogens .
4-1	336-339	Its	abstract|substance[17]	giv|new[17]	_	_
4-2	340-344	CEAE	substance|substance[17]	new|new[17]	_	_
4-3	345-352	extract	substance[17]	new[17]	_	_
4-4	353-362	exhibited	_	_	_	_
4-5	363-364	a	abstract[18]	giv[18]	coref	11-14[79_18]
4-6	365-379	broad-spectrum	abstract[18]	giv[18]	_	_
4-7	380-393	antimicrobial	abstract[18]	giv[18]	_	_
4-8	394-402	activity	abstract[18]	giv[18]	_	_
4-9	403-409	toward	_	_	_	_
4-10	410-417	various	place[19]	new[19]	_	_
4-11	418-427	microbial	place[19]	new[19]	_	_
4-12	428-433	types	place[19]	new[19]	_	_
4-13	434-443	including	place[19]	new[19]	_	_
4-14	444-458	drug-sensitive	place[19]|abstract[20]	new[19]|new[20]	_	_
4-15	459-462	and	place[19]|abstract[20]	new[19]|new[20]	_	_
4-16	463-482	multidrug-resistant	place[19]|abstract[20]	new[19]|new[20]	_	_
4-17	483-492	pathogens	place[19]|abstract[20]	new[19]|new[20]	_	_
4-18	493-494	.	_	_	_	_

#Text=It showed moderate — strong inhibitory effects with MICs values between 80 – 600 µg/mL on 10 different microbes .
5-1	495-497	It	place	giv	_	_
5-2	498-504	showed	_	_	_	_
5-3	505-513	moderate	_	_	_	_
5-4	514-515	—	_	_	_	_
5-5	516-522	strong	abstract[22]	new[22]	coref	6-6[30_22]
5-6	523-533	inhibitory	abstract[22]	new[22]	_	_
5-7	534-541	effects	abstract[22]	new[22]	_	_
5-8	542-546	with	abstract[22]	new[22]	_	_
5-9	547-551	MICs	abstract[22]|substance|abstract[24]	new[22]|new|new[24]	coref|coref|coref|coref	7-21[47_0]|10-12[70_24]|7-21[47_0]|10-12[70_24]
5-10	552-558	values	abstract[22]|abstract[24]	new[22]|new[24]	_	_
5-11	559-566	between	abstract[22]|abstract[24]	new[22]|new[24]	_	_
5-12	567-569	80	abstract[22]|abstract[24]|quantity[25]	new[22]|new[24]|new[25]	_	_
5-13	570-571	–	abstract[22]|abstract[24]|quantity[25]	new[22]|new[24]|new[25]	_	_
5-14	572-575	600	abstract[22]|abstract[24]|quantity[25]|quantity	new[22]|new[24]|new[25]|new	_	_
5-15	576-581	µg/mL	abstract[22]|abstract[24]|quantity[27]	new[22]|new[24]|new[27]	_	_
5-16	582-584	on	abstract[22]|abstract[24]|quantity[27]	new[22]|new[24]|new[27]	_	_
5-17	585-587	10	abstract[22]|abstract[24]|quantity[27]|animal[28]	new[22]|new[24]|new[27]|new[28]	coref	15-8[0_28]
5-18	588-597	different	abstract[22]|abstract[24]|quantity[27]|animal[28]	new[22]|new[24]|new[27]|new[28]	_	_
5-19	598-606	microbes	abstract[22]|abstract[24]|quantity[27]|animal[28]	new[22]|new[24]|new[27]|new[28]	_	_
5-20	607-608	.	_	_	_	_

#Text=Since many novel antibiotics exhibiting strong effects against multiple-drug resistant bacteria have been isolated from medicinal plant-associated endophytic Streptomyces spp. in the last decades , endophytic S. griseorubens MP42 could be a potential candidate for the production of valuable bioactive substances .
6-1	609-614	Since	_	_	_	_
6-2	615-619	many	substance[29]	new[29]	_	_
6-3	620-625	novel	substance[29]	new[29]	_	_
6-4	626-637	antibiotics	substance[29]	new[29]	_	_
6-5	638-648	exhibiting	_	_	_	_
6-6	649-655	strong	abstract[30]	giv[30]	coref	15-24[110_30]
6-7	656-663	effects	abstract[30]	giv[30]	_	_
6-8	664-671	against	_	_	_	_
6-9	672-685	multiple-drug	animal[31]	new[31]	coref	8-8[54_31]
6-10	686-695	resistant	animal[31]	new[31]	_	_
6-11	696-704	bacteria	animal[31]	new[31]	_	_
6-12	705-709	have	_	_	_	_
6-13	710-714	been	_	_	_	_
6-14	715-723	isolated	_	_	_	_
6-15	724-728	from	_	_	_	_
6-16	729-738	medicinal	_	_	_	_
6-17	739-755	plant-associated	_	_	_	_
6-18	756-766	endophytic	_	_	_	_
6-19	767-779	Streptomyces	abstract	new	_	_
6-20	780-784	spp.	_	_	_	_
6-21	785-787	in	_	_	_	_
6-22	788-791	the	time[33]	new[33]	_	_
6-23	792-796	last	time[33]	new[33]	_	_
6-24	797-804	decades	time[33]	new[33]	_	_
6-25	805-806	,	_	_	_	_
6-26	807-817	endophytic	animal[35]|person[36]	giv[35]|new[36]	coref|coref	6-32[37_36]|6-32[37_36]
6-27	818-820	S.	person|animal[35]|person[36]	giv|giv[35]|new[36]	_	_
6-28	821-833	griseorubens	animal[35]|person[36]	giv[35]|new[36]	_	_
6-29	834-838	MP42	person[36]	new[36]	_	_
6-30	839-844	could	_	_	_	_
6-31	845-847	be	_	_	_	_
6-32	848-849	a	person[37]	giv[37]	_	_
6-33	850-859	potential	person[37]	giv[37]	_	_
6-34	860-869	candidate	person[37]	giv[37]	_	_
6-35	870-873	for	person[37]	giv[37]	_	_
6-36	874-877	the	person[37]|abstract[38]	giv[37]|new[38]	_	_
6-37	878-888	production	person[37]|abstract[38]	giv[37]|new[38]	_	_
6-38	889-891	of	person[37]|abstract[38]	giv[37]|new[38]	_	_
6-39	892-900	valuable	person[37]|abstract[38]|substance[39]	giv[37]|new[38]|new[39]	_	_
6-40	901-910	bioactive	person[37]|abstract[38]|substance[39]	giv[37]|new[38]|new[39]	_	_
6-41	911-921	substances	person[37]|abstract[38]|substance[39]	giv[37]|new[38]|new[39]	_	_
6-42	922-923	.	_	_	_	_

#Text=In agreement with previous reports , the present study demonstrated the potential growth inhibiting effect of L. cubeba EO ( MICs of 0.70 – 5.5 mg/mL ) toward a broad array of microbial species , compared with EOs derived from other medicinal plants .
7-1	924-926	In	_	_	_	_
7-2	927-936	agreement	event[40]	new[40]	_	_
7-3	937-941	with	event[40]	new[40]	_	_
7-4	942-950	previous	event[40]|abstract[41]	new[40]|new[41]	_	_
7-5	951-958	reports	event[40]|abstract[41]	new[40]|new[41]	_	_
7-6	959-960	,	_	_	_	_
7-7	961-964	the	abstract[42]	new[42]	coref	10-1[64_42]
7-8	965-972	present	abstract[42]	new[42]	_	_
7-9	973-978	study	abstract[42]	new[42]	_	_
7-10	979-991	demonstrated	_	_	_	_
7-11	992-995	the	abstract[43]	new[43]	coref	18-17[132_43]
7-12	996-1005	potential	abstract[43]	new[43]	_	_
7-13	1006-1012	growth	abstract[43]	new[43]	_	_
7-14	1013-1023	inhibiting	_	_	_	_
7-15	1024-1030	effect	abstract[44]	new[44]	_	_
7-16	1031-1033	of	abstract[44]	new[44]	_	_
7-17	1034-1036	L.	abstract[44]|person|object[46]	new[44]|new|new[46]	coref|coref|coref|coref	10-5[66_46]|10-41|10-5[66_46]|10-41
7-18	1037-1043	cubeba	abstract[44]|object[46]	new[44]|new[46]	_	_
7-19	1044-1046	EO	abstract[44]|object[46]	new[44]|new[46]	_	_
7-20	1047-1048	(	_	_	_	_
7-21	1049-1053	MICs	substance[47]	giv[47]	_	_
7-22	1054-1056	of	substance[47]	giv[47]	_	_
7-23	1057-1061	0.70	substance[47]|abstract[48]	giv[47]|new[48]	_	_
7-24	1062-1063	–	substance[47]|abstract[48]	giv[47]|new[48]	_	_
7-25	1064-1067	5.5	substance[47]|abstract[48]|quantity[49]	giv[47]|new[48]|new[49]	_	_
7-26	1068-1073	mg/mL	substance[47]|abstract[48]|quantity[49]	giv[47]|new[48]|new[49]	_	_
7-27	1074-1075	)	_	_	_	_
7-28	1076-1082	toward	_	_	_	_
7-29	1083-1084	a	abstract[50]	new[50]	_	_
7-30	1085-1090	broad	abstract[50]	new[50]	_	_
7-31	1091-1096	array	abstract[50]	new[50]	_	_
7-32	1097-1099	of	abstract[50]	new[50]	_	_
7-33	1100-1109	microbial	abstract[50]|animal[51]	new[50]|giv[51]	coref	11-10[77_51]
7-34	1110-1117	species	abstract[50]|animal[51]	new[50]|giv[51]	_	_
7-35	1118-1119	,	_	_	_	_
7-36	1120-1128	compared	_	_	_	_
7-37	1129-1133	with	_	_	_	_
7-38	1134-1137	EOs	object	new	_	_
7-39	1138-1145	derived	_	_	_	_
7-40	1146-1150	from	_	_	_	_
7-41	1151-1156	other	plant[53]	new[53]	_	_
7-42	1157-1166	medicinal	plant[53]	new[53]	_	_
7-43	1167-1173	plants	plant[53]	new[53]	_	_
7-44	1174-1175	.	_	_	_	_

#Text=For instance , Ocimum gratissimum EO inhibited both Gram-positive bacteria ( S. aureus and Bacillus spp. ) at the concentration of 93.7 – 150 mg/mL and Gram-negative bacteria ( E. coli , P. aeruginosa , S .
8-1	1176-1179	For	_	_	_	_
8-2	1180-1188	instance	_	_	_	_
8-3	1189-1190	,	_	_	_	_
8-4	1191-1197	Ocimum	_	_	_	_
8-5	1198-1209	gratissimum	_	_	_	_
8-6	1210-1212	EO	_	_	_	_
8-7	1213-1222	inhibited	_	_	_	_
8-8	1223-1227	both	animal[54]	giv[54]	_	_
8-9	1228-1241	Gram-positive	animal[54]	giv[54]	_	_
8-10	1242-1250	bacteria	animal[54]	giv[54]	_	_
8-11	1251-1252	(	animal[54]	giv[54]	_	_
8-12	1253-1255	S.	animal[54]	giv[54]	_	_
8-13	1256-1262	aureus	animal[54]	giv[54]	_	_
8-14	1263-1266	and	animal[54]	giv[54]	_	_
8-15	1267-1275	Bacillus	animal[54]	giv[54]	_	_
8-16	1276-1280	spp.	animal[54]	giv[54]	_	_
8-17	1281-1282	)	animal[54]	giv[54]	_	_
8-18	1283-1285	at	animal[54]	giv[54]	_	_
8-19	1286-1289	the	animal[54]|abstract[55]	giv[54]|new[55]	_	_
8-20	1290-1303	concentration	animal[54]|abstract[55]	giv[54]|new[55]	_	_
8-21	1304-1306	of	animal[54]|abstract[55]	giv[54]|new[55]	_	_
8-22	1307-1311	93.7	animal[54]|abstract[55]|quantity	giv[54]|new[55]|new	_	_
8-23	1312-1313	–	animal[54]|abstract[55]	giv[54]|new[55]	_	_
8-24	1314-1317	150	animal[54]|abstract[55]|quantity[57]	giv[54]|new[55]|new[57]	_	_
8-25	1318-1323	mg/mL	animal[54]|abstract[55]|quantity[57]	giv[54]|new[55]|new[57]	_	_
8-26	1324-1327	and	animal[54]	giv[54]	_	_
8-27	1328-1341	Gram-negative	animal[54]|abstract	giv[54]|new	_	_
8-28	1342-1350	bacteria	animal[54]	giv[54]	_	_
8-29	1351-1352	(	_	_	_	_
8-30	1353-1355	E.	_	_	_	_
8-31	1356-1360	coli	_	_	_	_
8-32	1361-1362	,	_	_	_	_
8-33	1363-1365	P.	place[59]	new[59]	_	_
8-34	1366-1376	aeruginosa	place[59]	new[59]	_	_
8-35	1377-1378	,	_	_	_	_
8-36	1379-1380	S	person	new	_	_
8-37	1381-1382	.	_	_	_	_

#Text=Typhimurium , Klebsiella pneumoniae , Proteus mirabilis ) at the concentration of 107 – 750 mg/mL .
9-1	1383-1394	Typhimurium	_	_	_	_
9-2	1395-1396	,	_	_	_	_
9-3	1397-1407	Klebsiella	_	_	_	_
9-4	1408-1418	pneumoniae	_	_	_	_
9-5	1419-1420	,	_	_	_	_
9-6	1421-1428	Proteus	_	_	_	_
9-7	1429-1438	mirabilis	_	_	_	_
9-8	1439-1440	)	_	_	_	_
9-9	1441-1443	at	_	_	_	_
9-10	1444-1447	the	quantity[61]	new[61]	_	_
9-11	1448-1461	concentration	quantity[61]	new[61]	_	_
9-12	1462-1464	of	quantity[61]	new[61]	_	_
9-13	1465-1468	107	quantity[61]|quantity	new[61]|new	_	_
9-14	1469-1470	–	quantity[61]	new[61]	_	_
9-15	1471-1474	750	quantity[61]|quantity[63]	new[61]|new[63]	_	_
9-16	1475-1480	mg/mL	quantity[61]|quantity[63]	new[61]|new[63]	_	_
9-17	1481-1482	.	_	_	_	_

#Text=Another study showed that Cinnamomum EO ( Lauraceae family ) possessed low MIC values ranging from 1.2 to 12.5 mg/mL against E. coli , C. jejuni , S. aureus , S. enteritidis , S. Typhimurium , L. innocua , and L. monocytogenes .
10-1	1483-1490	Another	abstract[64]	giv[64]	coref	14-1[96_64]
10-2	1491-1496	study	abstract[64]	giv[64]	_	_
10-3	1497-1503	showed	_	_	_	_
10-4	1504-1508	that	_	_	_	_
10-5	1509-1519	Cinnamomum	plant|object[66]	new|giv[66]	coref|coref	11-7[75_66]|11-7[75_66]
10-6	1520-1522	EO	object[66]	giv[66]	_	_
10-7	1523-1524	(	_	_	_	_
10-8	1525-1534	Lauraceae	animal|person[68]	new|new[68]	_	_
10-9	1535-1541	family	person[68]	new[68]	_	_
10-10	1542-1543	)	_	_	_	_
10-11	1544-1553	possessed	_	_	_	_
10-12	1554-1557	low	abstract[70]	giv[70]	_	_
10-13	1558-1561	MIC	object|abstract[70]	new|giv[70]	coref	12-37[90_0]
10-14	1562-1568	values	abstract[70]	giv[70]	_	_
10-15	1569-1576	ranging	_	_	_	_
10-16	1577-1581	from	_	_	_	_
10-17	1582-1585	1.2	quantity	new	_	_
10-18	1586-1588	to	_	_	_	_
10-19	1589-1593	12.5	quantity[72]	new[72]	_	_
10-20	1594-1599	mg/mL	quantity[72]	new[72]	_	_
10-21	1600-1607	against	quantity[72]	new[72]	_	_
10-22	1608-1610	E.	quantity[72]	new[72]	_	_
10-23	1611-1615	coli	quantity[72]	new[72]	_	_
10-24	1616-1617	,	_	_	_	_
10-25	1618-1620	C.	_	_	_	_
10-26	1621-1627	jejuni	_	_	_	_
10-27	1628-1629	,	_	_	_	_
10-28	1630-1632	S.	_	_	_	_
10-29	1633-1639	aureus	_	_	_	_
10-30	1640-1641	,	_	_	_	_
10-31	1642-1644	S.	_	_	_	_
10-32	1645-1656	enteritidis	_	_	_	_
10-33	1657-1658	,	_	_	_	_
10-34	1659-1661	S.	_	_	_	_
10-35	1662-1673	Typhimurium	_	_	_	_
10-36	1674-1675	,	_	_	_	_
10-37	1676-1678	L.	_	_	_	_
10-38	1679-1686	innocua	_	_	_	_
10-39	1687-1688	,	_	_	_	_
10-40	1689-1692	and	_	_	_	_
10-41	1693-1695	L.	person	giv	_	_
10-42	1696-1709	monocytogenes	_	_	_	_
10-43	1710-1711	.	_	_	_	_

#Text=Thus , different chemical constituents in the EO of medicinal plant species affect their potential antimicrobial activity .
11-1	1712-1716	Thus	_	_	_	_
11-2	1717-1718	,	_	_	_	_
11-3	1719-1728	different	substance[74]	new[74]	_	_
11-4	1729-1737	chemical	substance[74]	new[74]	_	_
11-5	1738-1750	constituents	substance[74]	new[74]	_	_
11-6	1751-1753	in	substance[74]	new[74]	_	_
11-7	1754-1757	the	substance[74]|object[75]	new[74]|giv[75]	coref	12-17[0_75]
11-8	1758-1760	EO	substance[74]|object[75]	new[74]|giv[75]	_	_
11-9	1761-1763	of	substance[74]|object[75]	new[74]|giv[75]	_	_
11-10	1764-1773	medicinal	substance[74]|object[75]|animal[77]	new[74]|giv[75]|giv[77]	ana	11-14[0_77]
11-11	1774-1779	plant	substance[74]|object[75]|place|animal[77]	new[74]|giv[75]|new|giv[77]	_	_
11-12	1780-1787	species	substance[74]|object[75]|animal[77]	new[74]|giv[75]|giv[77]	_	_
11-13	1788-1794	affect	_	_	_	_
11-14	1795-1800	their	animal|abstract[79]	giv|giv[79]	coref|coref	16-8[115_0]|16-8[115_0]
11-15	1801-1810	potential	abstract[79]	giv[79]	_	_
11-16	1811-1824	antimicrobial	abstract[79]	giv[79]	_	_
11-17	1825-1833	activity	abstract[79]	giv[79]	_	_
11-18	1834-1835	.	_	_	_	_

#Text=Using E. coli as a model for exploring the mechanism of action of L. cubeba fruit EO , we demonstrated that EO-treated cells were rapidly killed after 2 h of treatment at the EO concentrations ≥ 2 MIC .
12-1	1836-1841	Using	_	_	_	_
12-2	1842-1844	E.	person	new	_	_
12-3	1845-1849	coli	_	_	_	_
12-4	1850-1852	as	_	_	_	_
12-5	1853-1854	a	_	_	_	_
12-6	1855-1860	model	_	_	_	_
12-7	1861-1864	for	_	_	_	_
12-8	1865-1874	exploring	_	_	_	_
12-9	1875-1878	the	abstract[81]	new[81]	_	_
12-10	1879-1888	mechanism	abstract[81]	new[81]	_	_
12-11	1889-1891	of	abstract[81]	new[81]	_	_
12-12	1892-1898	action	abstract[81]|abstract[82]	new[81]|new[82]	ana	13-1[0_82]
12-13	1899-1901	of	abstract[81]|abstract[82]	new[81]|new[82]	_	_
12-14	1902-1904	L.	abstract[81]|abstract[82]	new[81]|new[82]	_	_
12-15	1905-1911	cubeba	abstract[81]|abstract[82]	new[81]|new[82]	_	_
12-16	1912-1917	fruit	abstract[81]|abstract[82]	new[81]|new[82]	_	_
12-17	1918-1920	EO	abstract[81]|abstract[82]|object	new[81]|new[82]|giv	coref	12-34
12-18	1921-1922	,	_	_	_	_
12-19	1923-1925	we	person	acc	ana	14-1
12-20	1926-1938	demonstrated	_	_	_	_
12-21	1939-1943	that	_	_	_	_
12-22	1944-1954	EO-treated	object[85]	new[85]	coref	13-6[92_85]
12-23	1955-1960	cells	object[85]	new[85]	_	_
12-24	1961-1965	were	_	_	_	_
12-25	1966-1973	rapidly	_	_	_	_
12-26	1974-1980	killed	_	_	_	_
12-27	1981-1986	after	_	_	_	_
12-28	1987-1988	2	time[86]	new[86]	_	_
12-29	1989-1990	h	time[86]	new[86]	_	_
12-30	1991-1993	of	time[86]	new[86]	_	_
12-31	1994-2003	treatment	time[86]|abstract	new[86]|new	coref	18-3[127_0]
12-32	2004-2006	at	_	_	_	_
12-33	2007-2010	the	animal[89]	new[89]	_	_
12-34	2011-2013	EO	substance|animal[89]	giv|new[89]	coref	14-21[102_0]
12-35	2014-2028	concentrations	animal[89]	new[89]	_	_
12-36	2029-2030	≥	animal[89]	new[89]	_	_
12-37	2031-2032	2	animal[89]|object[90]	new[89]|giv[90]	_	_
12-38	2033-2036	MIC	animal[89]|object[90]	new[89]|giv[90]	_	_
12-39	2037-2038	.	_	_	_	_

#Text=It is worth noting that the cells showed extraordinary deformation and elongation .
13-1	2039-2041	It	abstract	giv	_	_
13-2	2042-2044	is	_	_	_	_
13-3	2045-2050	worth	_	_	_	_
13-4	2051-2057	noting	_	_	_	_
13-5	2058-2062	that	_	_	_	_
13-6	2063-2066	the	object[92]	giv[92]	_	_
13-7	2067-2072	cells	object[92]	giv[92]	_	_
13-8	2073-2079	showed	_	_	_	_
13-9	2080-2093	extraordinary	abstract[93]	new[93]	_	_
13-10	2094-2105	deformation	abstract[93]	new[93]	_	_
13-11	2106-2109	and	_	_	_	_
13-12	2110-2120	elongation	event	new	_	_
13-13	2121-2122	.	_	_	_	_

#Text=Our study found citral , carveol , and limonene as the main constituents , accounting together for 86.1 % of total L. cubeba fruit EO , concordant with previous studies .
14-1	2123-2126	Our	person|abstract[96]	giv|giv[96]	coref|coref	15-16[108_96]|15-16[108_96]
14-2	2127-2132	study	abstract[96]	giv[96]	_	_
14-3	2133-2138	found	_	_	_	_
14-4	2139-2145	citral	plant	new	coref	17-4
14-5	2146-2147	,	_	_	_	_
14-6	2148-2155	carveol	substance	new	coref	17-6
14-7	2156-2157	,	_	_	_	_
14-8	2158-2161	and	_	_	_	_
14-9	2162-2170	limonene	substance	new	coref	17-9
14-10	2171-2173	as	_	_	_	_
14-11	2174-2177	the	_	_	_	_
14-12	2178-2182	main	_	_	_	_
14-13	2183-2195	constituents	_	_	_	_
14-14	2196-2197	,	_	_	_	_
14-15	2198-2208	accounting	_	_	_	_
14-16	2209-2217	together	_	_	_	_
14-17	2218-2221	for	_	_	_	_
14-18	2222-2226	86.1	quantity[100]	new[100]	_	_
14-19	2227-2228	%	quantity[100]	new[100]	_	_
14-20	2229-2231	of	quantity[100]	new[100]	_	_
14-21	2232-2237	total	quantity[100]|object[102]	new[100]|giv[102]	coref	15-30[111_102]
14-22	2238-2240	L.	quantity[100]|object[102]	new[100]|giv[102]	_	_
14-23	2241-2247	cubeba	quantity[100]|object[102]	new[100]|giv[102]	_	_
14-24	2248-2253	fruit	quantity[100]|substance|object[102]	new[100]|new|giv[102]	_	_
14-25	2254-2256	EO	quantity[100]|object[102]	new[100]|giv[102]	_	_
14-26	2257-2258	,	_	_	_	_
14-27	2259-2269	concordant	_	_	_	_
14-28	2270-2274	with	_	_	_	_
14-29	2275-2283	previous	event[103]	new[103]	coref	15-13[107_103]
14-30	2284-2291	studies	event[103]	new[103]	_	_
14-31	2292-2293	.	_	_	_	_

#Text=Since the effect of each substance on microbes was examined separately in these studies , therefore , the present study aimed at investigating the antimicrobial inhibitory effects possessed by the total EO .
15-1	2294-2299	Since	_	_	_	_
15-2	2300-2303	the	abstract[104]	new[104]	_	_
15-3	2304-2310	effect	abstract[104]	new[104]	_	_
15-4	2311-2313	of	abstract[104]	new[104]	_	_
15-5	2314-2318	each	abstract[104]|substance[105]	new[104]|new[105]	_	_
15-6	2319-2328	substance	abstract[104]|substance[105]	new[104]|new[105]	_	_
15-7	2329-2331	on	abstract[104]|substance[105]	new[104]|new[105]	_	_
15-8	2332-2340	microbes	abstract[104]|substance[105]|animal	new[104]|new[105]|giv	_	_
15-9	2341-2344	was	_	_	_	_
15-10	2345-2353	examined	_	_	_	_
15-11	2354-2364	separately	_	_	_	_
15-12	2365-2367	in	_	_	_	_
15-13	2368-2373	these	event[107]	giv[107]	_	_
15-14	2374-2381	studies	event[107]	giv[107]	_	_
15-15	2382-2383	,	_	_	_	_
15-16	2384-2393	therefore	abstract[108]	giv[108]	_	_
15-17	2394-2395	,	abstract[108]	giv[108]	_	_
15-18	2396-2399	the	abstract[108]	giv[108]	_	_
15-19	2400-2407	present	abstract[108]	giv[108]	_	_
15-20	2408-2413	study	abstract[108]	giv[108]	_	_
15-21	2414-2419	aimed	_	_	_	_
15-22	2420-2422	at	_	_	_	_
15-23	2423-2436	investigating	_	_	_	_
15-24	2437-2440	the	abstract[110]	giv[110]	coref	16-4[114_110]
15-25	2441-2454	antimicrobial	abstract[110]	giv[110]	_	_
15-26	2455-2465	inhibitory	abstract|abstract[110]	new|giv[110]	coref	16-5
15-27	2466-2473	effects	abstract[110]	giv[110]	_	_
15-28	2474-2483	possessed	_	_	_	_
15-29	2484-2486	by	_	_	_	_
15-30	2487-2490	the	object[111]	giv[111]	coref	18-4[0_111]
15-31	2491-2496	total	object[111]	giv[111]	_	_
15-32	2497-2499	EO	object[111]	giv[111]	_	_
15-33	2500-2501	.	_	_	_	_

#Text=This combination showed broad-spectrum inhibitory effects against various microbial species tested .
16-1	2502-2506	This	abstract[112]	new[112]	_	_
16-2	2507-2518	combination	abstract[112]	new[112]	_	_
16-3	2519-2525	showed	_	_	_	_
16-4	2526-2540	broad-spectrum	abstract[114]	giv[114]	_	_
16-5	2541-2551	inhibitory	abstract|abstract[114]	giv|giv[114]	_	_
16-6	2552-2559	effects	abstract[114]	giv[114]	_	_
16-7	2560-2567	against	abstract[114]	giv[114]	_	_
16-8	2568-2575	various	abstract[114]|animal[115]	giv[114]|giv[115]	_	_
16-9	2576-2585	microbial	abstract[114]|animal[115]	giv[114]|giv[115]	_	_
16-10	2586-2593	species	abstract[114]|animal[115]	giv[114]|giv[115]	_	_
16-11	2594-2600	tested	_	_	_	_
16-12	2601-2602	.	_	_	_	_

#Text=In fact , citral , carveol , and limonene are phenolic substances with polarity characteristics that might act on the bacterial cell membrane , inactivate cell adhesions , and/or interact with the outer and inner membrane proteins .
17-1	2603-2605	In	_	_	_	_
17-2	2606-2610	fact	_	_	_	_
17-3	2611-2612	,	_	_	_	_
17-4	2613-2619	citral	plant	giv	_	_
17-5	2620-2621	,	_	_	_	_
17-6	2622-2629	carveol	substance	giv	_	_
17-7	2630-2631	,	_	_	_	_
17-8	2632-2635	and	_	_	_	_
17-9	2636-2644	limonene	substance	giv	coref	17-11[119_0]
17-10	2645-2648	are	_	_	_	_
17-11	2649-2657	phenolic	substance[119]	giv[119]	_	_
17-12	2658-2668	substances	substance[119]	giv[119]	_	_
17-13	2669-2673	with	substance[119]	giv[119]	_	_
17-14	2674-2682	polarity	substance[119]|abstract[120]	giv[119]|new[120]	_	_
17-15	2683-2698	characteristics	substance[119]|abstract[120]	giv[119]|new[120]	_	_
17-16	2699-2703	that	_	_	_	_
17-17	2704-2709	might	_	_	_	_
17-18	2710-2713	act	_	_	_	_
17-19	2714-2716	on	_	_	_	_
17-20	2717-2720	the	place[121]	new[121]	coref	17-36[0_121]
17-21	2721-2730	bacterial	place[121]	new[121]	_	_
17-22	2731-2735	cell	place[121]	new[121]	_	_
17-23	2736-2744	membrane	place[121]	new[121]	_	_
17-24	2745-2746	,	_	_	_	_
17-25	2747-2757	inactivate	_	_	_	_
17-26	2758-2762	cell	place|abstract[123]	new|new[123]	coref|coref	18-12|18-12
17-27	2763-2772	adhesions	abstract[123]	new[123]	_	_
17-28	2773-2774	,	_	_	_	_
17-29	2775-2781	and/or	_	_	_	_
17-30	2782-2790	interact	_	_	_	_
17-31	2791-2795	with	_	_	_	_
17-32	2796-2799	the	substance[125]	new[125]	_	_
17-33	2800-2805	outer	substance[125]	new[125]	_	_
17-34	2806-2809	and	substance[125]	new[125]	_	_
17-35	2810-2815	inner	substance[125]	new[125]	_	_
17-36	2816-2824	membrane	place|substance[125]	giv|new[125]	_	_
17-37	2825-2833	proteins	substance[125]	new[125]	_	_
17-38	2834-2835	.	_	_	_	_

#Text=Consequently , the EO treatment might result in the weakening of cell structure and inhibition of cell growth by creating holes on the cell wall and increasing the cell permeability .
18-1	2836-2848	Consequently	_	_	_	_
18-2	2849-2850	,	_	_	_	_
18-3	2851-2854	the	abstract[127]	giv[127]	_	_
18-4	2855-2857	EO	abstract|abstract[127]	giv|giv[127]	_	_
18-5	2858-2867	treatment	abstract[127]	giv[127]	_	_
18-6	2868-2873	might	_	_	_	_
18-7	2874-2880	result	_	_	_	_
18-8	2881-2883	in	_	_	_	_
18-9	2884-2887	the	event[128]	new[128]	_	_
18-10	2888-2897	weakening	event[128]	new[128]	_	_
18-11	2898-2900	of	event[128]	new[128]	_	_
18-12	2901-2905	cell	event[128]|place|abstract[130]	new[128]|giv|new[130]	coref|coref	18-24|18-24
18-13	2906-2915	structure	event[128]|abstract[130]	new[128]|new[130]	_	_
18-14	2916-2919	and	event[128]	new[128]	_	_
18-15	2920-2930	inhibition	event[128]|event[131]	new[128]|new[131]	_	_
18-16	2931-2933	of	event[128]|event[131]	new[128]|new[131]	_	_
18-17	2934-2938	cell	event[128]|event[131]|abstract[132]	new[128]|new[131]|giv[132]	_	_
18-18	2939-2945	growth	event[128]|event[131]|abstract[132]	new[128]|new[131]|giv[132]	_	_
18-19	2946-2948	by	_	_	_	_
18-20	2949-2957	creating	_	_	_	_
18-21	2958-2963	holes	object[133]	new[133]	_	_
18-22	2964-2966	on	object[133]	new[133]	_	_
18-23	2967-2970	the	object[133]|object[135]	new[133]|new[135]	_	_
18-24	2971-2975	cell	object[133]|place|object[135]	new[133]|giv|new[135]	coref	18-29
18-25	2976-2980	wall	object[133]|object[135]	new[133]|new[135]	_	_
18-26	2981-2984	and	_	_	_	_
18-27	2985-2995	increasing	_	_	_	_
18-28	2996-2999	the	abstract[137]	new[137]	_	_
18-29	3000-3004	cell	place|abstract[137]	giv|new[137]	_	_
18-30	3005-3017	permeability	abstract[137]	new[137]	_	_
18-31	3018-3019	.	_	_	_	_
